Cantitate/Preț
Produs
Total produse
Vezi coșul
Lymphohaematopoietic Growth Factors in Cancer Therapy II de Roland Mertelsmann

Lymphohaematopoietic Growth Factors in Cancer Therapy II: ESO Monographs

Editat de Roland Mertelsmann
en Limba Engleză Paperback – 16 dec 2011

Din seria ESO Monographs

  • 5% Antiandrogens in Prostate Cancer: A Key to Tailored Endocrine Treatment
    Preț: 69955 lei
  • 5% Endocrine Therapy of Breast Cancer: Concepts and Strategies
    Preț: 69955 lei
  • 5% Lymphohaematopoietic Growth Factors in Cancer Therapy
    Preț: 69721 lei
  • 5% Malignant Lymphomas: Biology and Treatment: An Update
    Preț: 70655 lei
  • 5% The Medical Management of Prostate Cancer
    Preț: 69827 lei
  • 5% Interferons: Mechanisms of Action and Role in Cancer Therapy
    Preț: 69506 lei
  • 5% Endocrine Therapy of Breast Cancer III
    Preț: 69506 lei
  • 5% Familial Cancer Control
    Preț: 70061 lei
  • 5% Breast Cancer Screening in Europe
    Preț: 70204 lei
  • 5% Prostate Cancer 2000
    Preț: 69756 lei
  • 5% Innovative Antimetabolites in Solid Tumours
    Preț: 69432 lei
  • 5% Biological Modulation of Solid Tumours by Interferons
    Preț: 69578 lei
  • 5% Current Topics in Lung Cancer
    Preț: 69650 lei
  • 5% Electropotentials in the Clinical Assessment of Breast Neoplasia
    Preț: 69578 lei
  • 5% The Medical Management of Prostate Cancer II
    Preț: 69827 lei
  • 5% Antiemetics in the Supportive Care of Cancer Patients
    Preț: 70204 lei
  • 5% Control of Growth Factors and Prevention of Cancer
    Preț: 69578 lei
  • 5% Neurological Adverse Reactions to Anticancer Drugs
    Preț: 107003 lei
  • 5% Retinoids in Oncology
    Preț: 107146 lei
  • 5% Psychosocial Aspects of Oncology
    Preț: 70168 lei
  • 5% Drug Delivery in Cancer Treatment II: Symptom Control, Cytokines, Chemotherapy
    Preț: 69883 lei
  • 5% Air Pollution and Human Cancer
    Preț: 106896 lei
  • 5% Diet and the Aetiology of Cancer
    Preț: 69578 lei
  • 5% Endocrine Therapy of Breast Cancer V
    Preț: 69812 lei
  • 5% New Approaches in Cancer Pharmacology: Drug Design and Development
    Preț: 35717 lei
  • 5% Endocrine Therapy of Breast Cancer IV
    Preț: 69792 lei
  • 5% Indoor and Outdoor Air Pollution and Human Cancer
    Preț: 70332 lei
  • 5% Endocrine Therapy of Breast Cancer VI
    Preț: 69792 lei
  • 5% Human Tumour Xenografts in Anticancer Drug Development
    Preț: 107562 lei
  • 5% Drug Delivery in Cancer Treatment III: Home Care — Symptom Control, Economy, Brain Tumours
    Preț: 70046 lei
  • 5% Management in Neuro-Oncology
    Preț: 69847 lei
  • 5% New Approaches to the Treatment of Leukemia
    Preț: 70620 lei
  • 5% The Role of Multiple Intensification in Medical Oncology
    Preț: 35361 lei
  • Magnetic Resonance in Oncology
    Preț: 38298 lei

Preț: 69991 lei

Preț vechi: 73674 lei
-5% Nou

Puncte Express: 1050
Preț estimativ în valută:
13401€ • 13955$ • 11119£

Carte tipărită la comandă

Livrare economică 14-28 februarie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642778032
ISBN-10: 3642778038
Pagini: 136
Ilustrații: VII, 123 p. 7 illus.
Dimensiuni: 210 x 277 x 7 mm
Greutate: 0.32 kg
Ediția:Softcover reprint of the original 1st ed. 1992
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria ESO Monographs

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Research

Cuprins

and Overview.- Lymphopoietic Growth Factors.- Pathophysiology of T-Cell Mediated Shock Induced by Bacterial Superantigens.- Natural Killer Cells and Interleukin-2-Activated Killer Cells.- Tumour Immunogenicity Induced by Exogenous Interleukins.- Cytokine Gene Therapy of Cancer.- Analysis of T-Cell Receptor Variability in Tumour Infiltrating Lymphocytes.- Clinical Studies with Interleukin-2: An Overview.- Clinical Trials with Local Administration of Lymphopoietic Growth Factors.- Clinical Trials with Interleukin-2. The Rome Experience.- Haematopoietic Growth Factors.- Lymphohaematopoietic Growth Factor Use in Lung Cancer Patients.- Clinical Trials with Haematopoietic Growth Factors and Peripheral Blood Stem Cells.